National Psoriasis Foundation Dallas soirée raises nearly $150,000

By AI, Created 4:37 PM UTC, May 18, 2026, /AGP/ – The National Psoriasis Foundation says its April 25 Dallas Soirée drew more than 175 supporters and raised nearly $150,000 for psoriatic disease research and advocacy. The event also honored two women leaders in the field and highlighted sponsors including Johnson & Johnson and Organon.

Why it matters: - The Dallas Soirée generated funds for psoriatic disease research, education and patient support. - NPF says the money will help advance earlier diagnostic tools for psoriatic arthritis, expand treatment options and support efforts toward a cure. - Psoriatic disease affects more than 8 million people in the U.S., giving the fundraiser broad public health relevance.

What happened: - The National Psoriasis Foundation hosted its annual Dallas Soirée on April 25, 2026, at the Fairmont Dallas. - The event brought together more than 175 supporters, advocates and leaders in healthcare and industry. - NPF says the evening raised nearly $150,000. - The fundraiser was framed as part of NPF’s broader mission to improve life for people living with psoriatic disease.

The details: - NPF honored two Women in Leadership Award recipients: Jennifer Cather, M.D., and Melodie Young, MSN, A/GNP-C. - The organization recognized both women for compassion, expertise and commitment to the psoriatic disease community. - Johnson & Johnson served as presenting sponsor. - Organon served as a progress sponsor. - NPF says sponsor support helps fuel research, expand educational resources and provide critical support for patients and families. - Leah M. Howard, J.D., NPF president and CEO, said the event showed what the community can accomplish together and that it is accelerating progress and bringing hope to millions of people. - NPF describes itself as the leading nonprofit representing people with psoriasis and psoriatic arthritis. - NPF directs readers to psoriasis.org for more information.

Between the lines: - The event paired fundraising with recognition, a common nonprofit strategy that can deepen donor engagement while elevating clinical and advocacy leaders. - The sponsor list signals continued industry involvement in psoriasis and psoriatic arthritis efforts. - NPF is using the Soirée to connect patient impact, research funding and leadership visibility in one event.

What’s next: - NPF says proceeds will continue supporting research initiatives and patient-facing resources. - The organization will likely keep using similar events to raise funds and public awareness around psoriatic disease. - Support for earlier diagnosis and broader treatment options remains a stated priority.